ReviewBMC urology2019
Urethral cavernous hemangioma: a highly misdiagnosed disease (a case report of two patients and literature review).
Review in BMC urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 19 citations in OpenAlex.
- Efficacy and safety of transurethral thulium laser cauterization in male patients with urethral hemangioma: a single-center retrospective case series.Translational andrology and urology · 2026Article
- A multicenter retrospective study of 108 men with urethral hemangioma.Translational andrology and urology · 2026Article
- Long-term outcome of male urethral hemangioma: a two-center study.Translational andrology and urology · 2026Article
- Posterior urethral hemangioma presenting as hematospermia in an adolescent male.Urology case reports · 2026Article
- Misdiagnosis of hematuria after catheterization: A case report and literature review of posterior urethral hemangioma in a pediatric male.Urology case reports · 2025Article
- Urethral Hemangioma Treated With Transurethral Coagulation Using Narrow-Band Imaging: A Case Report.Cureus · 2025Article
- Review
- Massive blood loss from urethrorrhage in a 16-year-old boy: Case report and review of two rare causes.Urology case reports · 2023Article
- Urethral hemangioma: How to investigate as a cause of hematuria after male sexual activities.IJU case reports · 2023Article
- One rare case of posterior urethral hemangioma and review of the literature.Urology case reports · 2022Article
- Clinical characteristics and endoscopic treatment of hematospermia with postcoital hematuria.BMC urology · 2020Article
- Recurrent Hemangioma of the Penile Urethra - An Unusual Etiology of Gross Hematuria Managed Successfully with Holmium Laser Coagulation.Journal of Indian Association of Pediatric SurgeonsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
Abstract
backgroundDiagnosis of urethral cavernous hemangioma (UCH) is very rare. It can be easy to misdiagnose and mistreat due to its atypical clinical manifestations and a lack of relevant knowledge. The study is to explore the diagnosis, differential diagnosis, and treatment of UCH. CASE PRESENTATION: The first patient was a 15-year-old male, who was admitted to the hospital for more than 1 year with repeated hematuria. UCH was diagnosed by cystoscope biopsy, and cured with local injection of pingyangmycin. The second patient was a 49-year-old male, who was admitted for repeated painless gross hematuria and intermittent urethral bleeding after penile erection for more than 20 years. The case had been misdiagnosed as seminal vesiculitis, urethritis, or prostatitis, for over 20 years, until it was diagnosed as UCH by MR examination of the penis. It was treated by injection of pingyangmycin into the hemangioma's lumen and base. A small incision in the ventral penile area was separated from the location of the hemangioma, which was injected with pingyangmycin again. A biopsy of resected tissue further confirmed the diagnosis of UCH.
conclusionsUCH is an easily misdiagnosed disease. Intermittent painless hematuria is important characteristic of UCH. Local injection of pingyangmycin is a good option for treatment of UCH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.